BRISTOL-MYERS SQUIBB secures contract for VARIOUS MEDICINAL PRODUCTS - Supply of active ingredients called "mavacamten 15 mg oral", "mavacamten 5 mg oral", "mavacamten 10 mg oral", "deucravacitinib 6mg" and "fedratinib 100 mg"

Spain, June 25 -- Spain based BRISTOL-MYERS SQUIBB has secured contract from Direccion Gerencia Hospital Universitario de Gran Canaria Doctor Negrin for VARIOUS MEDICINAL PRODUCTS - Supply of active ingredients called "mavacamten 15 mg oral", "mavacamten 5 mg oral", "mavacamten 10 mg oral", "deucravacitinib 6mg" and "fedratinib 100 mg". The value of the contract is worth 1093620 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....